Search results
NVAX Stock Alert: Novavax Just Hit a New 52-Week High
InvestorPlace· 3 days agoNovavax (NASDAQ:NVAX) stock investors are celebrating on Friday as the vaccine company’s shares hit...
Novavax (NVAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 6 days agoNovavax (NVAX) possesses the right combination of the two key ingredients for a likely earnings beat...
Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal
InvestorPlace· 3 days agoNovavax (NASDAQ:NVAX) stock has more than doubled today and is up more than 120% at the time of this...
Why Is Novavax (NVAX) Stock Up 118% Today?
InvestorPlace· 3 days agoNovavax (NASDAQ:NVAX) stock is on the rise Friday after the biotechnology company announced a deal with Sanofi (NASDAQ:SNY) alongside its first-quarter ...
Novavax (NVAX) Set to Announce Quarterly Earnings on Friday
ETF DAILY NEWS· 5 days agoNovavax (NASDAQ:NVAX – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Friday, May 10th. Analysts expect the company to announce ...
Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 3 days agoNovavax (NVAX) delivered earnings and revenue surprises of -0.96% and 7.30%, respectively, for the...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 3 days agoThe company's revenue was $93.85 million, significantly falling short of the consensus estimate of...
Why Is Macrogenics (MGNX) Stock Down 69% Today?
InvestorPlace· 3 days agoMacrogenics (NASDAQ:MGNX) stock is dropping hard on Friday after the after providing investors with a clinical trial update in its latest earnings...
Stock Market Today: Dow rides broadening out of rally to notch 4th weekly win By Investing.com
Investing.com· 4 days agoInvesting.com-- The Dow closed higher Friday to clinch its fourth-weekly win as the broadening out...
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 3 hours agoJust when the Covid-vaccine maker Novavax Inc.'s (NVAX) future as a going concern seemed uncertain, a remarkable turnaround has unfolded, thanks to the license deal with Sanofi ...